137 related articles for article (PubMed ID: 35524339)
1. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial.
Price CPE; Guo A; Stevens WW; Cousens L; Vu TT; Suh LA; Erickson KA; Conley D; Grammer LC; Kern RC; Tan BK; Kato A; Schleimer RP; Smith SS; Welch KC; Peters AT
Clin Exp Allergy; 2022 Jul; 52(7):859-867. PubMed ID: 35524339
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
[TBL] [Abstract][Full Text] [Related]
3. Systemic and topical antibiotics for chronic rhinosinusitis.
Head K; Chong LY; Piromchai P; Hopkins C; Philpott C; Schilder AG; Burton MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011994. PubMed ID: 27113482
[TBL] [Abstract][Full Text] [Related]
4. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.
Head K; Chong LY; Hopkins C; Philpott C; Schilder AG; Burton MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011992. PubMed ID: 27115214
[TBL] [Abstract][Full Text] [Related]
5. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
[TBL] [Abstract][Full Text] [Related]
7. Short-course oral steroids alone for chronic rhinosinusitis.
Head K; Chong LY; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011991. PubMed ID: 27113367
[TBL] [Abstract][Full Text] [Related]
8. Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps.
Van Gerven L; Langdon C; Cordero A; Cardelús S; Mullol J; Alobid I
Laryngoscope; 2018 Aug; 128(8):1743-1751. PubMed ID: 29114894
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
[TBL] [Abstract][Full Text] [Related]
10. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
11. Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
Tversky J; Lane AP; Azar A
Clin Exp Allergy; 2021 Jun; 51(6):836-844. PubMed ID: 33595845
[TBL] [Abstract][Full Text] [Related]
12. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E; Pasquini E; Trimarchi M; La Mantia I; Pagella F; Ottaviano G; Garzaro M; Pipolo C; Torretta S; Seccia V; Cantone E; Ciofalo A; Lucidi D; Fadda GL; Pafundi PC; Settimi S; Montuori C; Anastasi F; Pagliuca G; Ghidini A; Cavaliere C; Maffei M; Bussu F; Gallo S; Canevari FRM; Paludetti G; Galli J;
Allergy; 2023 Oct; 78(10):2669-2683. PubMed ID: 37203259
[TBL] [Abstract][Full Text] [Related]
14. Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
[TBL] [Abstract][Full Text] [Related]
15. The role of intranasal corticosteroids in chronic rhinosinusitis with nasal polyposis treated with dupilumab.
Pecorari G; Piazza F; Borgione M; Prizio C; Galli Della Mantica G; Garetto M; Gedda F; Riva G
Am J Otolaryngol; 2023; 44(5):103927. PubMed ID: 37245323
[TBL] [Abstract][Full Text] [Related]
16. Saline irrigation for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Glew S; Scadding G; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011995. PubMed ID: 27115216
[TBL] [Abstract][Full Text] [Related]
17. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.
Orlando P; Licci G; Kuitche D; Matucci A; Vultaggio A; Gallo O; Maggiore G
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1317-1324. PubMed ID: 37910208
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
Bachert C; Han JK; Desrosiers MY; Gevaert P; Heffler E; Hopkins C; Tversky JR; Barker P; Cohen D; Emson C; Martin UJ; Shih VH; Necander S; Kreindler JL; Jison M; Werkström V
J Allergy Clin Immunol; 2022 Apr; 149(4):1309-1317.e12. PubMed ID: 34599979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
